Methods of cost-effectiveness evaluation of endovascular patent foramen ovale closure for secondary prevention of cryptogenic stroke
- 23 April 2024
- journal article
- research article
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 27 (6)
Abstract
The review of articles devoted to the cost-effectiveness of percutaneous closure of the patent foramen ovale (PFO) from a taxpayer’s point of view has been conducted. A decrease in the incidence of recurrent ischaemic stroke is recorded in the correctly chosen patients after the percutaneous closure of the PFO. Patients with cryptogenic stroke associated with FPO are predominantly under the age of 60, that is, at the peak of economic performance and are vulnerable to long-term disability. To assess the cost-effectiveness of FPO closure in combination with different types of treatment, Markov’s models of patients with stroke in different studies, including six health conditions (stable post-stroke, transient ischaemic attack, post-transient ischaemic attack, clinical ischaemic stroke, post-clinical ischaemic stroke and death) were considered. Assessment of 5-year time horizon, costs and utility of FPO endovascular closure technology, incremental «cost-effectiveness» ratio (ICER) and total costs for quality-adjusted life year (QALY) has been conducted in comparison with medical treatment. Mechanisms and proposals for the use of appropriate models in the Russian patients’ population are outlined.Keywords
This publication has 26 references indexed in Scilit:
- Discounting in Economic EvaluationsPharmacoEconomics, 2018
- Cryptogenic Stroke and High-Risk Patent Foramen OvaleJACC, 2018
- Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after StrokeNew England Journal of Medicine, 2017
- Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the Amplatzer Patent Foramen Ovale OccluderThe American Journal of Cardiology, 2016
- Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based studyThe Lancet Neurology, 2015
- Cost Effectiveness of Percutaneous Closure Versus Medical Therapy for Cryptogenic Stroke in Patients With a Patent Foramen OvaleThe American Journal of Cardiology, 2014
- The percutaneous closure of patent foramen ovale (PFO): Impact on the quality of lifeInternational Journal of Cardiology, 2013
- Patent Foramen Ovale: Echocardiographic Detection and Clinical Relevance in StrokeJournal of the American Society of Echocardiography, 2010
- Patent Foramen Ovale and Cryptogenic Stroke: A Matter of Age?Seminars in Thrombosis and Hemostasis, 2009
- Patent Foramen Ovale and Cryptogenic Stroke in Older PatientsNew England Journal of Medicine, 2007